Proteon Therapeutics' Grant - III Round

Proteon Therapeutics raised a round of funding on June 24, 2009. Investors include Qualifying Therapeutic Discovery Project.

Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a human recombinant protein that aims to permanently dilate segments of blood vessels, blocks vasospasm, and reduce the formatio…

Articles about Proteon Therapeutics' Grant - III Round: